Cantargia: Orphan Drug Designation for CAN04 in Pancreatic Cancer in the US
Research Note
2021-09-23
11:13
Redeye has a positive view of Cantargia's obtaining orphan drug status. It provides some benefits, the most important of which are described in our comment.
RR
Richard Ramanius
Disclosures and disclaimers